1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with bilirubin in 5 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (bilirubin) | Trials (bilirubin) | Recent Studies (post-2010) (bilirubin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 25,921 | 1,337 | 5,871 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | bilirubin (IC50) |
|---|---|---|---|
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 3.3884 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.3183 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bremer, C; Lang, H; Oldhafer, KJ; Pichlmayr, R; Schüttler, W; Spiegel, HU | 1 |
| Borobia, FG; Escriba, JM; Fabregat, J; Farran, L; Figueras, J; Jaurrieta, E; Rafecas, A; Torras, J | 1 |
| Sereni, L; Tetta, C; Wratten, ML | 1 |
| Fukao, K; Fukunaga, K; Gu, M; Ishiguro, S; Otsuka, M; Seino, K; Takada, Y; Taniguchi, H; Todoroki, T; Yuzawa, K | 1 |
| Chmiel, B | 1 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bilirubin
| Article | Year |
|---|---|
Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Azepines; Bilirubin; Body Weight; Graft Survival; Liver; Liver Function Tests; Liver Transplantation; Platelet Activating Factor; Platelet Aggregation Inhibitors; Reperfusion Injury; Swine; Time Factors; Triazoles | 1995 |
Platelet-activating factor antagonist BN52021 improves survival in normothermic liver ischemia in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Diterpenes; Dose-Response Relationship, Drug; Ginkgolides; Graft Survival; Ischemia; Lactones; Liver Circulation; Liver Transplantation; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Wistar; Reperfusion Injury | 1993 |
Hemolipodialysis attenuates oxidative stress and removes hydrophobic toxins.
Topics: Animals; Antioxidants; Ascorbic Acid; Bilirubin; Blood Proteins; Cattle; Extracorporeal Circulation; Free Radical Scavengers; Humans; Liposomes; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Phosphatidylcholines; Phospholipids; Platelet Activating Factor; Renal Dialysis; Serum Albumin, Bovine; Toxins, Biological; Uremia; Vitamin E | 2000 |
Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors.
Topics: Animals; Bilirubin; Graft Survival; Liver; Liver Transplantation; Peptides, Cyclic; Platelet Activating Factor; Postoperative Period; Survival Rate; Swine; Tissue and Organ Procurement; Tissue Donors; Transplantation, Homologous | 2000 |
[The influence of select pathophysiologic factors of acute pancreatitis on erythrocytes' deformability examined in vitro].
Topics: Acetaldehyde; Acute Disease; Adult; Bilirubin; Cholagogues and Choleretics; Erythrocyte Deformability; Humans; In Vitro Techniques; Lipopolysaccharides; Oxidants; Pancreatitis; Platelet Activating Factor; Superoxides; Taurocholic Acid; Trypsin | 2002 |